{
    "organizations": [],
    "uuid": "24cd0d89216d4b8daa08d0e550815de77b4d5ed1",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-cytodyn-reports-primary-endpoint-a/brief-cytodyn-reports-primary-endpoint-achieved-in-pro-140-pivotal-combination-therapy-trial-in-hiv-infection-idUSFWN1QA0EJ",
    "ord_in_thread": 0,
    "title": "BRIEF-Cytodyn Reports Primary Endpoint Achieved In PRO 140 Pivotal Combination Therapy Trial In HIV Infection",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 20 (Reuters) - Cytodyn Inc:\n* CYTODYN REPORTS PRIMARY ENDPOINT ACHIEVED IN PRO 140 PIVOTAL COMBINATION THERAPY TRIAL IN HIV INFECTION\n* CYTODYN INC - TRIAL DATA SHOW A STATISTICALLY SIGNIFICANT REDUCTION IN HIV-1 RNA VIRAL LOAD OF GREATER THAN 0.5LOG WITH PRO 140 VERSUS PLACEBO\n* CYTODYN INC - TO DATE, PRO 140 HAS BEEN GENERALLY WELL TOLERATED WITH NO DRUG-RELATED MAJOR ADVERSE EVENTS OR TREATMENT DISCONTINUATION REPORTED Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-20T19:18:00.000+02:00",
    "crawled": "2018-02-21T21:46:56.006+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "cytodyn",
        "inc",
        "cytodyn",
        "report",
        "primary",
        "endpoint",
        "achieved",
        "pro",
        "pivotal",
        "combination",
        "therapy",
        "trial",
        "hiv",
        "infection",
        "cytodyn",
        "inc",
        "trial",
        "data",
        "show",
        "statistically",
        "significant",
        "reduction",
        "rna",
        "viral",
        "load",
        "greater",
        "pro",
        "versus",
        "placebo",
        "cytodyn",
        "inc",
        "date",
        "pro",
        "generally",
        "well",
        "tolerated",
        "major",
        "adverse",
        "event",
        "treatment",
        "discontinuation",
        "reported",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}